Others report that enhanced GIPR signaling (proxied by GIPR variants with reduced T2D risk) is associated with reduced BMI and triglyceride levels [42]; this analysis assumes that increased GIPR action reduces T2D risk which is not fully established. This evidence concerns the gene GIPR and type 2 diabetes mellitus.